Abstract: The present invention relates to a novel fused ring compound having urea structure that exhibits excellent NAMPT activating effect, and a method using the same for treating/preventing metabolic disorder, cardiovascular and kidney disease, mitochondrial disease, neurodegenerative disease, ocular disease, and muscle wasting disorder. The present invention provides a compound represented by following formula (I) or a pharmacologically acceptable salt: Formula (I) wherein A, B, R, R2 and R3 represent the same meanings as in the claims.

Abstract: Provided are a polyvinyl acetal sheet which is excellent in adhesion to glass, easy in control of adhesion, little colored, highly transparent and excellent in penetration resistance even under high-temperature conditions when the sheet is used for laminated glass or the like, a process for its production and a process for producing polyvinyl acetal particles used for the sheet. The polyvinyl acetal sheet is produced by molding polyvinyl acetal particles into a sheet with a degree of acetalization of from 75.0 to 84.0 mass % and with a porosity of from 60 to 85%. The polyvinyl acetal particles are preferably produced by an acetalization reaction of 100 parts by mass of a polyvinyl alcohol and from 40 to 75 parts by mass of an aldehyde in the presence of an acid catalyst at a reaction temperature of from 20 to 60° C.

Abstract: A chloroprene latex composition wherein the gel content of the chloroprene polymer is from 3 to 40 wt %, and the weight average molecular weight of the sol content is at least 400,000, and a chloroprene latex is presented which is excellent in the initial adhesive performance and normal adhesive performance and which has a good balance of heat resistance, water resistance, etc. with the adhesive properties.

Abstract: A chloroprene latex composition wherein the gel content of the chloroprene polymer is from 3 to 40 wt %, and the weight average molecular weight of the sol content is at least 400,000, and a chloroprene latex is presented which is excellent in the initial adhesive performance and normal adhesive performance and which has a good balance of heat resistance, water resistance, etc. with the adhesive properties.

Abstract: A chloroprene latex composition wherein the gel content of the chloroprene polymer is from 3 to 40 wt %, and the weight average molecular weight of the sol content is at least 400,000, and a chloroprene latex is presented which is excellent in the initial adhesive performance and normal adhesive performance and which has a good balance of heat resistance, water resistance, etc. with the adhesive properties.

Abstract: A chloroprene polymer composition containing an .alpha.,.beta.-unsaturated carboxylate polymer having a number average molecular weight of at least 300,000.

Abstract: A chloroprene polymer composition containing an .alpha.,.beta.-unsaturated carboxylate polymer having a number average molecular weight of at least 300,000.

Abstract: A compact pump assembly includes a plurality of axially aligned peristaltic pumps for activating the flow of liquids through the conduits. A housing containing the pumps, is provided with a removable cover for retaining the pumps in the housing when the cover is closed and for permitting removal of the pumps when the cover is opened. A reversible motor is mounted outside of the housing for driving each of the pumps. The pumps may be independently inactivated by an individual release mechanisms provided on the common closure cover.

Abstract: The device for controlling the amount of removed water by ultrafiltration can eliminate the scaling error completely by the use of the diaphragms in the scaling mechanism, and thus, the water elimination precision can be improved.

Abstract: The device for controlling the amount of removed water by ultrafiltration can eliminate the scaling error completely by the use of the diaphragms in the scaling mechanism, and thus, the water elimination precision can be improved.

Abstract: In an infusion pump or especially a peristaltic infusion pump of the type in which a drug liquid is forced to flow through an infusion tube by peristalsis, the pump mechanism can be readily pulled out of the main body. More specifically, the pump mechanism can be detachably fitted into and held at a predetermined position in a pump mechanism housing recess defined in an infusion pump casing and the pumping mechanism is then drivingly coupled through a suitable power transmission mechanism with a driving means disposed within the casing. And the pump mechanism is separated from the interior of the casing by means of the pump mechanism housing recess.